Eamon O’Kelly is an experienced litigator and advisor who focuses his practice on antitrust and trade regulation issues. A leader in the antitrust field, Eamon has represented Fortune 100 companies and European and Asian multinationals. Prior to joining Robins Kaplan LLP, Eamon led the antitrust group of a 1,500-lawyer international law firm, where he defended publically traded companies in significant “bet the company” litigation across a range of legal matters, including the Sherman Act, Federal Trade Commission Act, the Foreign Corrupt Practices Act (FCPA), the Racketeer Influenced and Corrupt Organizations Act (RICO) and others. He also represents clients in commercial litigation matters in federal and New York State courts, as well as in alternative dispute resolution. In addition to his litigation work, Eamon advises clients on regulatory issues, including pricing and distribution. Eamon’s achievements have been recognized by numerous organizations, and he has consistently been selected for inclusion in Best Lawyers, Chambers USA, and Super Lawyers.
101
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. The Australian competition law watchdog recently concluded an investigation into big technology’s market power, the first comprehensive investigation of its (...)
447
The Supreme Court recently issued a unanimous decision in a notable "price-squeeze" case under § 2 of the Sherman Act involving rival telecom companies. Pacific Bell Tel. Co. v. Linkline Commc’ns, Inc., No. 07-512 (Feb. 25, 2009). The Court held that a vertically integrated company that had (...)
1203
The Court of Appeals for the District of Columbia Circuit has overturned the Federal Trade Commission’s ruling against Rambus, Inc. (“Rambus”), finding that the Commission did not prove that Rambus’s failure to disclose certain intellectual property interests to a standard-setting organization (...)
329
On September 4, 2007, the Second Circuit Court of Appeals affirmed the dismissal of all claims in In re Elevator Antitrust Litigation, No. 06-2138-cv, 2007 WL 2471805 (2d Cir. Sept. 4, 2007) (slip opinion available at http://www.ca2.uscourts.gov), finding that the complaint failed to satisfy (...)
392
On September 4, 2007 the United States Court of Appeals for the Ninth Circuit issued its much-anticipated decision in Cascade Health Solutions (fka McKenzie- Williamette Hospital) v. PeaceHealth, et al., No. 05-35627, 2007 WL 2473229 (9th Cir. Sept. 4, 2007). The court held that bundled (...)
1153
In a decision announced earlier today, the United States Supreme Court held that federal securities laws implicitly preclude the application of antitrust laws to claims filed against ten leading investment banks over alleged conduct on initial public offerings during the technology boom of the (...)
